[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360763-105":59,"doc-detail-360763-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-preclinical-mouse-model-mimicking-the-ovarian-cancer-induced-estrogen-deficiency-depression-axis","A preclinical mouse model mimicking the ovarian cancer-induced estrogen deficiency-depression axis","","Young ovarian cancer patients frequently show a combined relationship between tumor progression, estrogen deficiency, and depression, which worsens prognosis and quality of life. Yet, a preclinical model that reproduces this triad has been missing. This study developed and validated a novel mouse model integrating ovarian cancer modeling with chronic restraint stress, and manipulated estrogen status by ovary retention or ovariectomy at defined timepoints. Behavioral, neuroendocrine, and tumor progression readouts confirmed robust, clinically relevant hypoestrogenic ovarian cancer–related depression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-preclinical-mouse-model-mimicking-the-ovarian-cancer-induced-estrogen-deficiency-depression-axis/360763/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-preclinical-mouse-model-mimicking-the-ovarian-cancer-induced-estrogen-deficiency-depression-axis/360763.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s goal for the mouse model?","Question",{"text":112,"@type":113},"To develop and validate a preclinical mouse model that recapitulates the ovarian cancer–induced estrogen deficiency–depression axis and supports translational research.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was estrogen status manipulated in the model?",{"text":117,"@type":113},"Estrogen status was adjusted using ovary retention or ovariectomy (OVX), either 1 day before tumor implantation to model preexisting deficiency or 7 days after implantation to mimic abrupt treatment-induced hormonal loss.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supported the model’s validity?",{"text":121,"@type":113},"Validity was assessed with behavioral assays (sucrose preference, tail suspension, open field), neuroendocrine profiling, and longitudinal evaluation of tumor progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360763,1791562939,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10. 1002/ame2 .70161  \nOR I G I NAL ART I C L E  \nA preclinical mouse model mimicking the ovarian cancerinduced estrogen deficiency-depression axis  \nJiamin Liu1 | Yafei Yang2 | Chunxi Liu1 | Danting Wen1 | Tingyu Zhao3 | Ping Xie3 | Jing Xiao1,4   \n1Department of Gynecology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China  \n2The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen University, Shenzhen, Guangdong, China  \n3 Department of Gynecology, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China  \n4State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou, Guangdong, China  \nCorrespondence  \nPing Xie, Department of Gynecology, Affiliated Hospital of Chengdu, University of Traditional Chinese Medicine, Chengdu, Sichuan, China. [Email:](Email: 452040453@qq.com)[ 452040453@qq.com](Email: 452040453@qq.com)  \nJing Xiao, Department of Gynecology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. [Email:](Email: xiaojingson_2004@gzucm.edu.cn)[ xiaojingson_2004@gzucm.edu.cn](Email: xiaojingson_2004@gzucm.edu.cn)  \nFunding information  \nNational Natural Science Foundation of China, Grant/Award Number: 82374504; LiuMinru Academic Experience Inheritance Studio of Guangdong Provincial Hospital of Chinese Medicine, Grant/Award Number: DF02202; YuYun Academic Experience Inheritance Studio of Guangdong Provincial Hospital of Chinese Medicine, Grant/Award Number:  \nE43728; Guangdong Provincial Hospital of Chinese Medicine, Grant/Award Number: YN2025GZR53  \nAbstract  \nBackground: Young ovarian cancer (OC) patients often experience a synergistic interplay among tumor progression, estrogen deficiency, and depression, which severely compromises prognosis and quality of life. However, a preclinical model that faithfully recapitulates this triad remains lacking. This study aimed to develop and validate a novel mouse model to investigate the interrelationship between ovarian cancer, hypoestrogenic states, and depression.  \nMethods: An ovarian cancer–related depression (OCRD) model was established by integrating previously validated components of tumor-depression paradigms, including ID-8 ovarian cancer modeling and chronic restraint stress-induced depressive-like behavior. Orthotopic (intraperitoneal) and heterotopic (subcutaneous) tumor models were combined with chronic stress. Estrogen status was manipulated by ovary retention or ovariectomy (OVX), performed either 1 day before tumor implantation to model preexisting estrogen deficiency or 7 days after engraftment to mimic treatmentinduced abrupt hormonal loss. Model validity was assessed using behavioral assays (sucrose preference test, tail suspension test, and open field test), neuroendocrine profiling, and longitudinal evaluation of tumor progression.  \nResults: The model generated by intraperitoneal tumor engraftment, OVX, and chronic stress exhibited pronounced depressive-like behavior, accompanied by marked estrogen depletion and accelerated tumor progression. All mice survived throughout the experimental period, indicating high model stability and reproducibility. This integrated phenotype closely mirrors key clinical features observed in young OC patients undergoing abrupt estrogen deprivation.  \nConclusions: The combination of intraperitoneal ovarian cancer modeling, ovariectomy, and chronic stress induction establishes a stable and clinically relevant preclinical model of hypoestrogenic ovarian cancer–related depression, suitable for translational research.  \nK E Y WO R D S  \nchronic restraint stress, hypoestrogenism, mice model, ovarian cancer–related depression, ovariectomy  \nJiamin Liu and Yafei Yang contributed equally to this work.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distr","cbCaikVMXe3LNa0Y","https://ap.wps.com/l/cbCaikVMXe3LNa0Y","pdf",7456986,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the study’s goal for the mouse model?\",\"answer\":\"To develop and validate a preclinical mouse model that recapitulates the ovarian cancer–induced estrogen deficiency–depression axis and supports translational research.\"},{\"question\":\"How was estrogen status manipulated in the model?\",\"answer\":\"Estrogen status was adjusted using ovary retention or ovariectomy (OVX), either 1 day before tumor implantation to model preexisting deficiency or 7 days after implantation to mimic abrupt treatment-induced hormonal loss.\"},{\"question\":\"What evidence supported the model’s validity?\",\"answer\":\"Validity was assessed with behavioral assays (sucrose preference, tail suspension, open field), neuroendocrine profiling, and longitudinal evaluation of tumor progression.\"}]","A preclinical mouse model mimicking the ovarian cancer-induced estrogen deficiency-depression axis | PDF",1790141480,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46db15369e86c05a2213d4e65bdddf24.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e0c86a22a1f2295cffc2bcc57980255.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8734603e5a5c15269488b8de6035e7e.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4668d47216982f602f065bfe295e7e47.webp",980,1287]